2 mg of retatrutide Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type Diabetes Trial Retatrutide Dosing: Schedules and What

Diabetes Care 38: 12631273, 2015

In this weight management program subjects treated with liraglutide 3.0 mg experienced a dose-dependent weight loss ranging from 6.0 kg to 8.8 kg, whereas subjects treated with placebo (on diet and exercise alone) had a mean weight loss of 0.2 kg to 3.0 k (209)

The SURMOUNT-5 trial found approximately 20.2% average body-weight loss with branded tirzepatide versus 13.7% with branded semaglutide over 72 weeks

Or the ones with partially disclosed formulas

Toxicology in Vitro 54: 317329

These medications work by regulating appetite, improving blood sugar control, and slowing gastric emptying, which helps reduce cravings and promote consistent fat loss